Literature DB >> 19917349

Down-regulation of cyclooxygenase-2 is involved in ischemic postconditioning protection against renal ischemia reperfusion injury in rats.

Y Yun1, W G Duan, P Chen, H X Wu, Z Q Shen, Z Y Qian, D H Wang.   

Abstract

Ischemic postconditioning (IPostC) is a phenomenon whereby rapid intermittent interruptions of blood flow in the early phase of reperfusion protect an organ from ischemia-reperfusion injury. In the present study, we investigated whether the protective effect of IPostC was associated with the cyclooxygenase-2 (COX-2) pathway by evaluating its expression following renal ischemia-reperfusion in rats. Animals underwent 45 minutes of renal pedicle occlusion followed by reperfusion for 1.5, 3, 6, 12, or 24 hours. IPostC was performed by six 10-second cycles of reperfusion and 10 seconds of renal pedicle occlusion at the end of ischemia. Blood and kidney samples were collected at each reperfusion time point. The protein expression of COX-1 and COX-2 were evaluated by Western blotting. Our data showed that IPostC attenuated the renal dysfunction and decreased COX-2 expression induced by ischemia-reperfusion insults. The results indicated that the protective effect of IPostC was related to down-regulation of COX-2 expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19917349     DOI: 10.1016/j.transproceed.2009.06.209

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  2 in total

1.  Oxidative stress mediates chemical hypoxia-induced injury and inflammation by activating NF-κb-COX-2 pathway in HaCaT cells.

Authors:  Chuntao Yang; Hongzhong Ling; Meifen Zhang; Zhanli Yang; Xiuyu Wang; Fanqin Zeng; Chuhuai Wang; Jianqiang Feng
Journal:  Mol Cells       Date:  2011-04-20       Impact factor: 5.034

Review 2.  Preclinical Evidence for the Efficacy of Ischemic Postconditioning against Renal Ischemia-Reperfusion Injury, a Systematic Review and Meta-Analysis.

Authors:  Simone J Jonker; Theo P Menting; Michiel C Warlé; Merel Ritskes-Hoitinga; Kimberley E Wever
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.